PHG Foundation

Recent papers from PHG Foundation

1. Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO StudyJournal of Clinical Oncology · 2026
2. Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategiesClinical Cancer Research · 2026
3. SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancerClinical Cancer Research · 2026
4. Analysis of a large osteosarcoma sequencing data set elucidates patterns of genomic alterationsCancer · 2026
5. Clinical validation of tissue and liquid companion diagnostics for BRAF V600E detection in non-small cell lung cancers from the PHAROS studyCancer Research Communications · 2026
6. Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatmentCancer Research Communications · 2026
7. Recommendations on post-trial responsibility in implantable neural device research: a multidisciplinary consensus studyBMC Medical Ethics · 2026
8. Optimising rapid prenatal exome sequencing in the NHS genomic medicine service: the EXPRESS Synopsis.2026
9. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular diseaseEuropean Heart Journal · 2024
10. Evaluating sustainability indicators employed across European arable agricultural research. A systematic literature reviewEnvironment Development and Sustainability · 2026
11. Homologous Recombination Deficiency and Genomic Alterations in Advanced Prostate Cancer: Insights for Precision TherapyThe Oncologist · 2026
12. The pan-tumor landscape of gene amplifications and copy number amplification ratio for established and emerging clinical targetsClinical Cancer Research · 2026
13. The role of microbial genomics in delivering the UK’s national action plan for confronting antimicrobial resistance 2024–29The Lancet Microbe · 2026
14. Succinate dehydrogenase B deficient renal cell carcinoma (RCC): A genomic landscape study.Journal of Clinical Oncology · 2026
15. MTAP loss in penile squamous cell carcinoma (penSCC): A genomic landscape study.Journal of Clinical Oncology · 2026
16. Fanconi Anemia Complementation Group C Gene (FANCC) Association with Hereditary and Sporadic Renal TumorsThe Oncologist · 2026
17. Clinical determinants of survival and a predictive immune biomarker for immunotherapy in fibrolamellar carcinoma: A comprehensive institutional analysis.Journal of Clinical Oncology · 2026
18. Personalized prevention of neurodegenerative diseases: scoping review and evidence gap mapAlzheimer s & Dementia · 2025
19. Coverage of Actionable Alterations In Non-Small Cell Lung Cancer by Hybrid Capture-Based FoundationOne®CDx Compared With Amplicon-based Oncomine™ DXThe Oncologist · 2025
20. Data quality, provenance and transparency in real-world data : Aligning quality standards with data governance legal frameworksJournal of data protection & privacy. · 2025